查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1611416

睡眠辅助市场：依产品、睡眠障碍、通路 - 2025-2030 年全球预测

Sleep Aids Market by Product (Mattresses & Pillows, Medications, Sleep Apnea Devices), Sleep-Disorder (Insomnia, Narcolepsy, Restless Legs Syndrome), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年睡眠辅助市场的市场规模为593.2亿美元，预计2024年将达到641.5亿美元，复合年增长率为5.98%，到2030年将达到891.1亿美元。

睡眠辅助市场包括各种旨在帮助个人获得更好睡眠的产品和服务。此类别包括镇静剂和安眠药等药品、褪黑激素补充品等非处方药以及智慧睡眠面罩和睡眠追踪应用程式等设备。由于压力和快节奏的生活方式会加剧失眠、睡眠呼吸中止症和其他睡眠障碍，因此需要助眠剂。其应用范围从医疗机构、健康中心到个人家庭使用。最终用户包括患有睡眠问题的成年人、面临自然睡眠下降的老年人，甚至是受萤幕时间影响的青少年。睡眠重要性意识的提高、睡眠障碍发病率的上升以及睡眠技术的进步推动了市场的成长。然而，安眠药依赖带来的耻辱和对副作用的担忧也起到了一定作用。草药补充品和数位疗法等自然和替代睡眠解决方案存在巨大机会，这反映了国家向整体健康实践的转变。建议包括投资研究和开发非成瘾性睡眠辅助工具和使用者友善的睡眠技术。市场面临药品监管严格、使用者需求多样化、冥想、瑜珈等传统疗法的竞争等挑战。创新已经成熟，包括用于更准确睡眠追踪的生物感测器、人工智慧驱动的个人化睡眠解决方案以及结合多个健康指标资料的整合应用程式。市场动态是动态的，其特点是技术快速进步以及对无缝融入日常生活的安全有效解决方案的强烈偏好。为了利用这一不断变化的格局，公司应专注于建立多功能产品线，以满足寻求医疗和非医疗睡眠改善解决方案的不同消费者群体的需求。

主要市场统计
基准年[2023] 593.2亿美元
预计年份 [2024] 641.5亿美元
预测年份 [2030] 891.1亿美元
复合年增长率（%） 5.98%

市场动态：快速发展的睡眠辅助市场的关键市场洞察

供需的动态交互作用正在改变睡眠辅助市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 对各种睡眠状况的治疗和​​诊断的需求不断增加
    • 提高大众对睡眠障碍的认识
    • 穿戴式感测器和追踪设备的接受度不断提高
  • 市场限制因素
    • 睡眠辅助设备校准不当
  • 市场机会
    • 助眠新科技介绍
    • 政府增加研发经费竞标大型睡眠辅助设备
  • 市场挑战
    • 缺乏适当的授权文件

波特的五力：驾驭睡眠辅助市场的策略工具

波特的五力框架是了解睡眠辅助市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解睡眠辅助市场的外部影响

外部宏观环境因素在塑造助眠剂市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解睡眠辅助市场的竞争格局

对睡眠辅助市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵睡眠辅助市场供应商的绩效评估

FPNV定位矩阵是评估睡眠辅助市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了睡眠辅助市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对睡眠辅助市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对各种睡眠障碍的治疗和诊断的需求日益增长。
      • 提高大众对睡眠障碍的认识
      • 穿戴式感测器和追踪设备的采用增加
    • 抑制因素
      • 助眠器调整不当
    • 机会
      • 助眠新科技介绍
      • 政府对研发 (R&D) 的资助增加导致睡眠辅助产品的大举竞标
    • 任务
      • 缺乏授权许可所需的适当文件
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章睡眠辅助市场：副产品

  • 床垫和枕头
  • 药品
    • 草药
    • 非处方药
    • 处方药
  • 睡眠呼吸中止症装置
    • 自适应人工呼吸器伺服(ASV)
    • 脸部介面
    • 口腔矫正器
    • 正压呼吸器(PAP)设备

第七章睡眠辅助市场睡眠障碍

  • 失眠
  • 发作性睡病
  • 不宁腿
  • 睡眠呼吸中止症
  • 梦游

第八章睡眠辅助市场：按分销管道

  • 药局
  • 电子商务
  • 医院药房
  • 零售药房

第九章美洲睡眠辅助市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太睡眠辅助市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的睡眠辅助市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Apnea Sciences Corporation
  • Boehringer Ingelheim International GmbH
  • Cadwell Industries Inc.
  • Cleveland Medical Devices Inc.
  • Compumedics Limited
  • Drive DeVilbiss Healthcare Inc.
  • Eisai Co., Ltd.
  • Fisher & Paykel Healthcare Corp. Ltd.
  • Koninklijke Philips NV
  • Merck and Co. Inc.
  • Natus Medical Inc.
  • Nihon Kohden Corporation
  • Pfizer Inc.
  • ResMed Inc.
  • Sanofi SA
Product Code: MRR-AD517FAA7863

The Sleep Aids Market was valued at USD 59.32 billion in 2023, expected to reach USD 64.15 billion in 2024, and is projected to grow at a CAGR of 5.98%, to USD 89.11 billion by 2030.

The sleep aids market encompasses a variety of products and services designed to help individuals achieve better sleep. This category includes pharmaceuticals like sedatives and hypnotics, over-the-counter remedies such as melatonin supplements, and devices like smart sleep masks and sleep tracking apps. The necessity for sleep aids arises from the prevalent issues of insomnia, sleep apnea, and other sleep disorders exacerbated by increasingly stressful and fast-paced lifestyles. Their application spans healthcare facilities, wellness centers, and individual use at home. End users include adults struggling with sleep problems, older demographics facing natural sleep decline, and even teenagers affected by screen time. Market growth is driven by increasing awareness of the importance of sleep, rising incidence of sleep disorders, and advancements in sleep technology. However, it's also influenced by the stigma of dependence on sleep medications and concerns about side effects. A significant opportunity lies in natural and alternative sleep solutions like herbal supplements and digital therapeutics, reflecting a public shift toward holistic health practices. Recommendations include investing in research and development of non-addictive sleep aids and user-friendly sleep technology. The market faces challenges such as stringent regulations in pharmaceuticals, variability in user needs, and competition from traditional practices like meditation and yoga. Innovation is ripe in biosensors for more accurate sleep tracking, AI-driven personalized sleep solutions, and integrative apps that combine data from multiple health metrics. The sleep aids market is dynamic, characterized by rapid technological advancements and a strong preference for safe, effective solutions that fit seamlessly into daily life. To capitalize on this evolving landscape, companies should focus on building versatile product lines that cater to a diverse consumer base seeking both medical and non-medical sleep improvement solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 59.32 billion
Estimated Year [2024] USD 64.15 billion
Forecast Year [2030] USD 89.11 billion
CAGR (%) 5.98%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Sleep Aids Market

The Sleep Aids Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need for treating & diagnosing different forms of sleep conditions
    • Rising public awareness of the sleep disorders
    • Growing acceptance of wearable sensors and tracking devices
  • Market Restraints
    • Inappropriate calibration of devices of sleeping aids
  • Market Opportunities
    • Introduction of novel technologies in sleeping aids
    • Growing government funding for research & development (R&D) to bid huge sleep aids
  • Market Challenges
    • Absence of appropriate documents for the permitting license

Porter's Five Forces: A Strategic Tool for Navigating the Sleep Aids Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Sleep Aids Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Sleep Aids Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Sleep Aids Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Sleep Aids Market

A detailed market share analysis in the Sleep Aids Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Sleep Aids Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Sleep Aids Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Sleep Aids Market

A strategic analysis of the Sleep Aids Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Sleep Aids Market, highlighting leading vendors and their innovative profiles. These include Apnea Sciences Corporation, Boehringer Ingelheim International GmbH, Cadwell Industries Inc., Cleveland Medical Devices Inc., Compumedics Limited, Drive DeVilbiss Healthcare Inc., Eisai Co., Ltd., Fisher & Paykel Healthcare Corp. Ltd., Koninklijke Philips N. V., Merck and Co. Inc., Natus Medical Inc., Nihon Kohden Corporation, Pfizer Inc., ResMed Inc., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Sleep Aids Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Mattresses & Pillows, Medications, and Sleep Apnea Devices. The Medications is further studied across Herbal Drugs, OTC Drugs, and Prescription-Based Drugs. The Sleep Apnea Devices is further studied across Adaptive Servo-Ventilators (ASVs), Facial Interfaces, Oral Appliances, and Positive Airway Pressure (PAP) Devices.
  • Based on Sleep-Disorder, market is studied across Insomnia, Narcolepsy, Restless Legs Syndrome, Sleep Apnea, and Sleep Walking.
  • Based on Distribution Channel, market is studied across Drug Stores, E-Commerce, Hospital Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for treating & diagnosing different forms of sleep conditions
      • 5.1.1.2. Rising public awareness of the sleep disorders
      • 5.1.1.3. Growing acceptance of wearable sensors and tracking devices
    • 5.1.2. Restraints
      • 5.1.2.1. Inappropriate calibration of devices of sleeping aids
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of novel technologies in sleeping aids
      • 5.1.3.2. Growing government funding for research & development (R&D) to bid huge sleep aids
    • 5.1.4. Challenges
      • 5.1.4.1. Absence of appropriate documents for the permitting license
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Sleep Aids Market, by Product

  • 6.1. Introduction
  • 6.2. Mattresses & Pillows
  • 6.3. Medications
    • 6.3.1. Herbal Drugs
    • 6.3.2. OTC Drugs
    • 6.3.3. Prescription-Based Drugs
  • 6.4. Sleep Apnea Devices
    • 6.4.1. Adaptive Servo-Ventilators (ASVs)
    • 6.4.2. Facial Interfaces
    • 6.4.3. Oral Appliances
    • 6.4.4. Positive Airway Pressure (PAP) Devices

7. Sleep Aids Market, by Sleep-Disorder

  • 7.1. Introduction
  • 7.2. Insomnia
  • 7.3. Narcolepsy
  • 7.4. Restless Legs Syndrome
  • 7.5. Sleep Apnea
  • 7.6. Sleep Walking

8. Sleep Aids Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Drug Stores
  • 8.3. E-Commerce
  • 8.4. Hospital Pharmacies
  • 8.5. Retail Pharmacies

9. Americas Sleep Aids Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Sleep Aids Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Sleep Aids Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Apnea Sciences Corporation
  • 2. Boehringer Ingelheim International GmbH
  • 3. Cadwell Industries Inc.
  • 4. Cleveland Medical Devices Inc.
  • 5. Compumedics Limited
  • 6. Drive DeVilbiss Healthcare Inc.
  • 7. Eisai Co., Ltd.
  • 8. Fisher & Paykel Healthcare Corp. Ltd.
  • 9. Koninklijke Philips N. V.
  • 10. Merck and Co. Inc.
  • 11. Natus Medical Inc.
  • 12. Nihon Kohden Corporation
  • 13. Pfizer Inc.
  • 14. ResMed Inc.
  • 15. Sanofi S.A.

LIST OF FIGURES

  • FIGURE 1. SLEEP AIDS MARKET RESEARCH PROCESS
  • FIGURE 2. SLEEP AIDS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SLEEP AIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SLEEP AIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SLEEP AIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SLEEP AIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SLEEP AIDS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SLEEP AIDS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SLEEP AIDS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SLEEP AIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SLEEP AIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SLEEP AIDS MARKET DYNAMICS
  • TABLE 7. GLOBAL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SLEEP AIDS MARKET SIZE, BY MATTRESSES & PILLOWS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SLEEP AIDS MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SLEEP AIDS MARKET SIZE, BY HERBAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SLEEP AIDS MARKET SIZE, BY OTC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SLEEP AIDS MARKET SIZE, BY PRESCRIPTION-BASED DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SLEEP AIDS MARKET SIZE, BY ADAPTIVE SERVO-VENTILATORS (ASVS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SLEEP AIDS MARKET SIZE, BY FACIAL INTERFACES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SLEEP AIDS MARKET SIZE, BY ORAL APPLIANCES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SLEEP AIDS MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SLEEP AIDS MARKET SIZE, BY INSOMNIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SLEEP AIDS MARKET SIZE, BY NARCOLEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SLEEP AIDS MARKET SIZE, BY RESTLESS LEGS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP WALKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SLEEP AIDS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SLEEP AIDS MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SLEEP AIDS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SLEEP AIDS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES SLEEP AIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 240. SLEEP AIDS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 241. SLEEP AIDS MARKET, FPNV POSITIONING MATRIX, 2023